Abbildung von: Plant-Derived Anticancer Drugs in the OMICS Era - Apple Academic Press Inc.

Plant-Derived Anticancer Drugs in the OMICS Era

Biosynthesis, Functions, and Applications
Deepu PanditaAnu Pandita(Herausgeber*in)
Apple Academic Press Inc.
Erschienen am 27. Oktober 2023
322 Seiten
ePUB ohne DRM
978-1-000-85219-6 (ISBN)
53,99 €inkl. 7% MwSt.
für ePUB ohne DRM
E-Book Einzellizenz
Als Download verfügbar
The current anti-cancer synthetic medicines are deemed inefficient and unsafe, state the editors of this new book. Plant-based lead molecules, however, such as taxol, camptothecin, podophyllotoxins, vinblastine, vincristine, homoharringtonine, and numerous other anticancer compounds from nature's arsenal, are potentially safe and can be powerful alternatives that effectively fight against cancer.

The volume looks at a variety of medicinal plants and approaches that have shown beneficial results against cancer. Topics in the book include Unani approaches of anticancer plants, genetic engineering and CRISPR/CAS-mediated editing to enhance a plant's anticancer potential, computational approaches used in anticancer plants, and more. The volume also examines the metabolomics of plants that give them anti-cancer properties.
Taylor & Francis Ltd
Für höhere Schule und Studium
24 Tables, black and white; 13 Line drawings, color; 22 Line drawings, black and white; 9 Halftones, color; 22 Illustrations, color; 22 Illustrations, black and white
978-1-000-85219-6 (9781000852196)
Schweitzer Klassifikation
Thema Klassifikation
DNB DDC Sachgruppen
Dewey Decimal Classfication (DDC)
BIC 2 Klassifikation
BISAC Klassifikation
Deepu Pandita is a Senior Lecturer in the Government Department of School Education, Jammu, India. She has more than 19 years of teaching experience. She has published editorials, book chapters, reviews, and research articles in journals of national and international repute and also acts as a reviewer, associate editor, and editor of several international journals. She has presented her research at professional conferences and has received awards for her work.

Anu Pandita is a Dietician at Vatsalya Clinic, Krishna Nagar, New Delhi, India. Previously she worked as a lecturer at Bee Enn College of Nursing, Talab Tillo, Jammu, India, and as a Dietician at Ahinsa Dham Bhagwan Mahavir Charitable Health Centre, New Delhi, India. She conducted a case study at the Pediatric Gastroenterology Ward at Nehru Hospital, PGI, Chandigarh, India, on a patient suffering from chronic liver disease. She has published books, book chapters, and research articles in journals of national and international repute and has also presented her research at national and international conferences.

Titles of related interest from Deepu Pandita and Anu Pandita:

* Antidiabetic Plants for Drug Discovery: Pharmacology, Secondary Metabolite Profiling,

and Ingredients with Insulin Mimetic Activity

* Plant Transposable Elements: Biology and Biotechnology

* CRISPR/Cas-Mediated Genome Editing in Plants

* Antidiabetic Potential of Plants in the Era of Omics

* Potent Anticancer Medicinal Plants: Secondary Metabolite Profiling, Active Ingredients,

and Pharmacological Outcomes
1. Evaluation of Extracts from Curcu malonga and Zingiber officinale as Growth Inhibitors of HeLa and HuH-7 Cell Lines 2. Role of Herbal Medicines in Liver Cancer 3. Unani Approaches of Anticancer Plants Against Cancer 4. Exploration of Anticancer Medicinal Plants of Northern Hemisphere 5. Genetic Engineering of Plants for Enhanced Anticancer Potential 6. Genetic Engineering of Plants of Enhancing Secondary Metabolites with Anti-Cancerous Properties 7. Genomics of Plants with Anticancer Properties: Breaking New Ground in Cancer Therapy 8. Metabolomics of Anti-Cancer Plants 9. Computational Approaches Used in Anticancer Plants 10. CRISPR/CAS-Mediated Editing of Anticancer Plants 11. Zinc Finger Nuclease (ZFNs) and Transcription Activator-Like Effector Nucleases (TALENs): Based Genome Editing in Enhancement of Anticancer Activity of Plants

Dateiformat: ePUB
Kopierschutz: ohne DRM (Digital Rights Management)


  • Computer (Windows; MacOS X; Linux): Verwenden Sie eine Lese-Software, die das Dateiformat ePUB verarbeiten kann: z.B. Adobe Digital Editions oder FBReader – beide kostenlos (siehe E-Book Hilfe).
  • Tablet/Smartphone (Android; iOS): Installieren Sie bereits vor dem Download die kostenlose App Adobe Digital Editions oder die App PocketBook (siehe E-Book Hilfe).
  • E-Book-Reader: Bookeen, Kobo, Pocketbook, Sony, Tolino u.v.a.m. (nicht Kindle)

Das Dateiformat ePUB ist sehr gut für Romane und Sachbücher geeignet – also für „glatten” Text ohne komplexes Layout. Bei E-Readern oder Smartphones passt sich der Zeilen- und Seitenumbruch automatisch den kleinen Displays an.
Ein Kopierschutz bzw. Digital Rights Management wird bei diesem E-Book nicht eingesetzt.

Weitere Informationen finden Sie in unserer  E-Book Hilfe.